AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models

Title
AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models
Authors
Keywords
Bcl2-like 11 (BIM), MEK1/2 inhibitor, Cisplatin, KRAS, NSCLC
Journal
CANCER LETTERS
Volume 358, Issue 1, Pages 85-91
Publisher
Elsevier BV
Online
2014-12-23
DOI
10.1016/j.canlet.2014.12.041

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search